Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,806 | 1,025 | 2,744 | 8,268 | 10,222 |
| Marketable Securities | 7,857 | 6,783 | 8,865 | 75 | 57 |
| Receivables | 811 | 1,745 | 1,016 | 1,057 | 2,961 |
| TOTAL | $14,474 | $9,553 | $12,625 | $9,400 | $13,240 |
| Non-Current Assets | |||||
| PPE Net | 49 | 50 | 54 | 50 | 28 |
| Other Non-Current Assets | 116 | 77 | 63 | 73 | 58 |
| TOTAL | $165 | $127 | $117 | $123 | $86 |
| Total Assets | $14,639 | $9,680 | $12,742 | $9,523 | $13,326 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,111 | 1,314 | 1,016 | 892 | 1,182 |
| TOTAL | $2,153 | $2,359 | $2,059 | $1,269 | $1,819 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,002 | 1,002 | 1,002 | 334 | 603 |
| Other Non-Current Liabilities | 62 | 25 | 14 | 24 | 15 |
| TOTAL | $3,152 | $3,366 | $3,605 | $2,180 | $1,966 |
| Total Liabilities | $5,305 | $5,725 | $5,664 | $3,449 | $3,785 |
| Shareholders' Equity | |||||
| Common Shares | 43,716 | 37,008 | 37,008 | 33,036 | 32,936 |
| Retained earnings | -133,966 | -130,566 | -127,347 | -125,469 | -121,836 |
| Other shareholders' equity | 1,127 | 1,127 | 1,127 | 1,127 | 1,127 |
| TOTAL | $9,334 | $3,955 | $7,078 | $6,074 | $9,541 |
| Total Liabilities And Equity | $14,639 | $9,680 | $12,742 | $9,523 | $13,326 |